Bioceres Crop Solutions Corp. (BIOX) Earnings History
Net Loss10 years of earnings data (2017–2026) · Currently unprofitable on a TTM basis
Loading earnings history...
Bioceres Crop Solutions Corp. (BIOX) Earnings Overview
As of November 7, 2026, Bioceres Crop Solutions Corp. (BIOX) reported trailing twelve-month net income of -$230M, reflecting +9.8% year-over-year growth. The company earned $-3.62 per diluted share over the past four quarters, with a net profit margin of -96.8%.
Looking at the long-term picture, BIOX's historical earnings data spans multiple years. The company achieved its highest annual net income of $19M in fiscal 2023.
Bioceres Crop Solutions Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PGEN ($24M net income, -2588.2% margin), FMC (-$4.26B net income, -64.6% margin), CTVA ($1.01B net income, 6.3% margin), BIOX has outperformed on profitability metrics. Compare BIOX vs PGEN →
BIOX Earnings vs Peers
Earnings metrics vs comparable public companies
BIOX Historical Earnings Data (2017–2026)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | -$230M | -315.6% | $100,000 | $-0.74 | -96.8% | 0.0% |
| 2025 | -$55M | -1808.8% | $-761,904 | $-0.82 | -16.6% | -0.2% |
| 2024 | $3M | -82.7% | $45M | $0.05 | 0.7% | 9.6% |
| 2023 | $19M | +360.8% | $54M | $0.30 | 4.5% | 12.9% |
| 2022 | -$7M | -4.8% | $40M | $-0.17 | -2.2% | 12.1% |
| 2021 | -$7M | -304.5% | $38M | $-0.18 | -3.3% | 18.6% |
| 2020 | $3M | +118.3% | $39M | $0.09 | 1.9% | 22.7% |
| 2019 | -$18M | -66.4% | $32M | $-0.60 | -11.5% | 20.0% |
| 2018 | -$11M | +6.6% | $16M | $-0.39 | -8.3% | 11.8% |
| 2017 | -$12M | - | $-706,924 | $-0.42 | -12.6% | -0.8% |
Download Data
Export BIOX earnings history in CSV or JSON format
Free sign-in required to download data
BIOX Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BIOX — Frequently Asked Questions
Quick answers to the most common questions about buying BIOX stock.
What is BIOX earnings per share (EPS)?
BIOX trailing twelve-month (TTM) diluted EPS is $-3.62, reflecting +9.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2026 is available in the table on this page.
What is Bioceres Crop Solutions Corp.'s net income?
Bioceres Crop Solutions Corp. (BIOX) trailing twelve-month net income is $-230M as of 2026. Earnings grew +9.8% year-over-year.
Is BIOX profitable?
BIOX is not currently profitable on a TTM basis, reporting a net loss of $-230M. Net margin is -96.8%. Investors should monitor for a return to profitability.
What is BIOX's earnings growth rate?
BIOX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2026.
What are BIOX's profit margins?
Bioceres Crop Solutions Corp. net profit margin is -96.8%, operating margin is +0.0%, and gross margin is +34.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -128.2%.
Is BIOX growing earnings?
BIOX is growing earnings steadily. YoY EPS growth of +9.8% is consistent with the 5-year CAGR of N/A. TTM net income is $-230M.
What was BIOX's best earnings year?
Bioceres Crop Solutions Corp.'s highest annual net income on record is $19M, achieved in fiscal year 2023. Earnings history on this page spans 2017 to 2026 and includes all annual and quarterly figures.
What were BIOX's earnings last quarter?
BIOX's most recent reported quarter was Q4 2026. Net income was $-28M with diluted EPS of $-0.39. For a full breakdown of all quarters, see the quarterly earnings table on this page.